Lobbying client

ROMARK GLOBAL PHARMA, LLC

Pharmaceutical product distributor

Filings
10
Filed by
1
Reported in-house
—
Reported by firms
$120,000

Reported lobbying by year

The larger of in-house and firm-reported each year, $ thousands 2022 to 2024

Filings

6 filings for 2023, newest first.
Filing Filed by Amount
4th Quarter - Report
4th Quarter 2023
BROWNSTEIN HYATT FARBER SCHRECK, LLP — reported
3rd Quarter - Report
3rd Quarter 2023
BROWNSTEIN HYATT FARBER SCHRECK, LLP — reported
1st Quarter - Amendment
1st Quarter 2023
BROWNSTEIN HYATT FARBER SCHRECK, LLP $60,000 reported
2nd Quarter - Amendment
2nd Quarter 2023
BROWNSTEIN HYATT FARBER SCHRECK, LLP $40,000 reported
2nd Quarter - Reportreplaced
2nd Quarter 2023
BROWNSTEIN HYATT FARBER SCHRECK, LLP $60,000 reported
1st Quarter - Reportreplaced
1st Quarter 2023
BROWNSTEIN HYATT FARBER SCHRECK, LLP $110,000 reported

Filed by

Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.

FirmReportsAmount
BROWNSTEIN HYATT FARBER SCHRECK, LLP 7 $120,000

Issues lobbied

How many report sections named each issue, counting the current version of each report.

IssueCodeMentions
Pharmacy PHA 6

Bills named in its filings

Bill numbers found in the filers' descriptions, most often named first.

BillCongressTimes named
H.R. 2617 117th 1

From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.